Insiders · ORKA

Daniel J Mitchell

Director at ARCA biopharma, Inc. (ORKA)

Daniel J Mitchell has filed 2 insider reports with the SEC since December 2022, as director at ARCA biopharma, Inc. (ORKA). The latest filing, on January 31, 2024, reports grant or award at ARCA biopharma, Inc. (ORKA).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Daniel J Mitchell is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
ARCA biopharma, Inc. logo
ORKA
ARCA biopharma, Inc.
Director611$95.81Jan 31, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Daniel J Mitchell with

Other insiders at the same companies

Questions about Daniel J Mitchell

What is Daniel J Mitchell's role at ARCA biopharma, Inc.?
Daniel J Mitchell reports to the SEC as director at ARCA biopharma, Inc. (ORKA), according to the latest filing on January 31, 2024.
How many shares does Daniel J Mitchell own?
After the latest filing that states it, Daniel J Mitchell directly owned 611 shares of ARCA biopharma, Inc. (ORKA). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Daniel J Mitchell bought or sold stock recently?
No open-market purchases or sales by Daniel J Mitchell are on file. The filings report grant or award.
How do I get alerts when Daniel J Mitchell files?
Follow Daniel J Mitchell on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Daniel J Mitchell (SEC CIK 0001113661). Totals count each trade once, skipping amendments whose original is on file, from Dec 19, 2022 on. View on SEC EDGAR · Get this as JSON